BetterLife Pharma (BETRF) Other Operating Expenses (2012 - 2026)

BetterLife Pharma's Other Operating Expenses history runs 15 years deep, the most recent figure standing at -$199.88 for Q2 2026.

• In Q2 2026, Other Operating Expenses rose 50.45% year-over-year to -$199.88; the TTM figure through Apr 2026 stood at -$603.98 (down 100.04% YoY), while the FY2026 annual figure was -$489.27, down 7817.34% from the prior year.
• Other Operating Expenses for Q2 2026 stood at -$199.88, down from -$0.73 in the prior quarter.
• The five-year high for Other Operating Expenses was $1.6 million in Q2 2024, with the low at -$46723.8 in Q1 2022.
• The 5-year median for Other Operating Expenses is $2.22 (2024), against an average of $257744.8.
• The sharpest annual moves came in 2023 and 2024: Other Operating Expenses sank 101.33% in 2023, then soared 67958643.44% in 2024.
• BetterLife Pharma's Other Operating Expenses stood at $13995.5 in 2022, then slumped by 100.01% to -$0.74 in 2023, then jumped by 67958643.44% to $501190.1 in 2024, then plunged by 100.0% to -$0.73 in 2025, then sank by 27364.78% to -$199.88 in 2026.
• Business Quant data shows BETRF's Other Operating Expenses at -$199.88 in Q2 2026, -$0.73 in Q3 2025, and -$403.37 in Q2 2025.